Literature DB >> 20173787

Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations.

B E Shaw1, L Ball, M Beksac, M Bengtsson, D Confer, S Diler, M Fechter, H Greinix, M Koh, S Lee, G Nicoloso-De-Faveri, J Philippe, S Pollichieni, M Pulsipher, A Schmidt, E Yang, A-M van Walraven.   

Abstract

Since the beginning of hematopoietic stem cell harvesting from volunteer unrelated donors, ensuring donor safety has been a necessary goal of all parties involved in the process. As donation of BM or PBSCs is not in the interest of the donor's own physical health, donor registries and transplantation centers must take into account both medical and ethical aspects involved in the donation procedure. One of the principal goals leading to the formation of the World Marrow Donor Association (WMDA) was to establish internationally acceptable standards for all aspects of unrelated donor care.

Entities:  

Mesh:

Year:  2010        PMID: 20173787     DOI: 10.1038/bmt.2010.2

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  16 in total

1.  Use of biosimilar filgrastim compared with lenograstim in autologous haematopoietic stem-cell transplant and in sibling allogeneic transplant.

Authors:  Shab Uddin; Pippa Russell; Maresa Farrell; Barbara Davy; Joe Taylor; Samir G Agrawal
Journal:  Ther Adv Hematol       Date:  2015-04

2.  Protecting the Health and Safety of Cell and Tissue Donors.

Authors:  David F Stroncek; Lee England
Journal:  ISBT Sci Ser       Date:  2015-04-01

3.  The impact of improved JACIE standards on the care of related BM and PBSC donors.

Authors:  C Anthias; M E Ethell; M N Potter; A Madrigal; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2014-11-10       Impact factor: 5.483

4.  Recommendations for managing the donation of haematopoietic stem cells from related and unrelated donors for allogeneic transplantation.

Authors:  Giuseppe Aprili; Alberto Bosi; Letizia Lombardini; Simonetta Pupella; Aurora Vassanelli
Journal:  Blood Transfus       Date:  2013-01-23       Impact factor: 3.443

5.  The devil is in the details: confidentiality challenges in the age of genetics.

Authors:  Barbara J Daly; Ashley Rosko; Shulin Zhang; Hillard M Lazarus
Journal:  HEC Forum       Date:  2015-03

Review 6.  A review of the haematopoietic stem cell donation experience: is there room for improvement?

Authors:  A Billen; J A Madrigal; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2014-01-27       Impact factor: 5.483

7.  Related haploidentical donors are a better choice than matched unrelated donors: Counterpoint.

Authors:  Bronwen E Shaw
Journal:  Blood Adv       Date:  2017-02-14

8.  Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study.

Authors:  Galen E Switzer; Jessica Bruce; Deidre M Kiefer; Hati Kobusingye; Rebecca Drexler; RaeAnne M Besser; Dennis L Confer; Mary M Horowitz; Roberta J King; Bronwen E Shaw; Marcie Riches; Brandon Hayes-Lattin; Michael Linenberger; Brian Bolwell; Scott D Rowley; Mark R Litzow; Michael A Pulsipher
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-14       Impact factor: 5.742

9.  Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.

Authors:  Michael A Pulsipher; Pintip Chitphakdithai; Brent R Logan; Bronwen E Shaw; John R Wingard; Hillard M Lazarus; Edmund K Waller; Matthew Seftel; David F Stroncek; Angela M Lopez; Dipnarine Maharaj; Peiman Hematti; Paul V O'Donnell; Alison W Loren; Susan F Leitman; Paolo Anderlini; Steven C Goldstein; John E Levine; Willis H Navarro; John P Miller; Dennis L Confer
Journal:  Blood       Date:  2012-10-29       Impact factor: 22.113

10.  Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.

Authors:  Michael A Pulsipher; Pintip Chitphakdithai; Brent R Logan; Willis H Navarro; John E Levine; John P Miller; Bronwen E Shaw; Paul V O'Donnell; Navneet S Majhail; Dennis L Confer
Journal:  Blood       Date:  2014-04-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.